reference/2247965

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2247965

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	354
issn	0269-2813 1365-2036
issueIdentifier	3
pageRange	347-354
publicationName	Alimentary Pharmacology & Therapeutics
startingPage	347
bibliographicCitation	Talley NJ, Lauritsen K, Tunturi-Hihnala H, Lind T, Moum B, Bang C, Schulz T, Omland TM, Delle M, Junghard O. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther. 2001 Mar;15(3):347–54. doi: 10.1046/j.1365-2036.2001.00943.x. PMID: 11207509.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3bd54d2a1ec31defbd359f91e3bd561b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_015c791ec97323cca466d465df81ccc6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40543d794b12613f1389106ce612d262 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60eb049759740fe173bfd192362b6c76 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bea1e2b3ac17369422bff6273d8d34a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5214d13ba4ccf0df1b8794dbaa0b57c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fafd95cc677a340ec7bc01879e0c2b57 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa7fae2cc4fbe8c7e591a23c34556187 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf9f9a0f3f5d957b20008f69d5765998 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f0111cc253a3d087564a33f496a32ba
date	2001-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/11207509 https://doi.org/10.1046/j.1365-2036.2001.00943.x
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1160 https://portal.issn.org/resource/ISSN/1365-2036 https://portal.issn.org/resource/ISSN/0269-2813
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Esomeprazole 20 mg maintains symptom control in endoscopy‐negative gastro‐oesophageal reflux disease: a controlled trial of ‘on‐demand’ therapy for 6 months
discusses	http://id.nlm.nih.gov/mesh/M0427109 http://id.nlm.nih.gov/mesh/M0504077 http://id.nlm.nih.gov/mesh/M0001340 http://id.nlm.nih.gov/mesh/M0015293
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000897Q000494 http://id.nlm.nih.gov/mesh/D009853Q000494 http://id.nlm.nih.gov/mesh/D054328 http://id.nlm.nih.gov/mesh/D005764Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D009853Q000737 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D013237 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D009853Q000008 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D017060 http://id.nlm.nih.gov/mesh/D064098 http://id.nlm.nih.gov/mesh/D004724 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000897Q000008 http://id.nlm.nih.gov/mesh/D005764Q000473 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7810 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0f3c36396b4022bf2219ee625452a634 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_253b653277908a873c242da1c5cfa8a7 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9568614 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7932 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9579578

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129288905 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129288902

Total number of triples: 64.